Comment on: "EU's new pharmacovigilance legislation: considerations for biosimilars"
- PMID: 24338043
- DOI: 10.1007/s40264-013-0128-5
Comment on: "EU's new pharmacovigilance legislation: considerations for biosimilars"
Comment in
-
Author's reply to Borg et al. Comment on: "EU's new pharmacovigilance legislation: considerations for biosimilars".Drug Saf. 2014 Feb;37(2):125-6. doi: 10.1007/s40264-013-0130-y. Drug Saf. 2014. PMID: 24338045 No abstract available.
Comment on
-
EU's new pharmacovigilance legislation: considerations for biosimilars.Drug Saf. 2014 Jan;37(1):9-18. doi: 10.1007/s40264-013-0121-z. Drug Saf. 2014. PMID: 24190573
References
-
- Nat Biotechnol. 2011 Aug 05;29(8):690-3 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
